Formation of ion-pairs in aqueous solutions of diclofenac salts

International Journal of Pharmaceutics

Volumn 187, Issue 2, 1999, Pages 163-173

  Fini, A ^a   Fazio, G ^a   Gonzalez Rodriguez, M ^a   Cavallari, C ^a   Passerini, N ^a   Rodriguez, L ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Association constant; Diclofenac salts; Extraction constant; Ion pairs; Organic and inorganic cations; Partition coefficient

Indexed keywords

CATION; DICLOFENAC;

AQUEOUS SOLUTION; ARTICLE; DRUG SOLUBILITY; HYDROPHOBICITY; IN VITRO STUDY; PARTITION COEFFICIENT; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; ELECTRIC CONDUCTIVITY; SOLUBILITY; SOLUTIONS;

EID: 0032876528     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00180-5     Document Type: Article

References (41)

1. Assandri, A., Canali, S., Giachetti, C., 1993. Local tolerability and pharmacokinetic profile of a new transdermal delivery system, diclofenac hydroxyethyl pyrrolidine plaster. Drugs Exp. Clin. Res. XIX, 89-95.
2. Berge, S.M., Bighley, L.D., Moukouse, D.C., 1977. Pharmaceutical salts. J. Pharm. Sci. 66, 1-19.
3. Bucci, R., Carunchio, V., Magrì, A.D., Magrì, A.L., 1993. On analytical behavior and complexing ability of diclofenac with transition metals. Euroanalysis IX, Bologna (Italy) September 1-7.
4. Castellari, C, Ottani, S., 1995. Anti-inflammatory drugs. II. Salt of 2-(2,6-dichlorophenyl amino) phenylacetic acid with diethanolamine. Acta Crystallogr. C51, 2612-2615.
5. Castellari, C, Ottani, S., 1996. Diclofenac salts. IV. Tris(2-hydroxyethyl)-ammonium 2-(2,6-diclhlorophenylamino)-phenylacetate. Acta Crystallogr. C52, 2619-2622.
6. Castellari, C, Ottani, S., 1997. Antiinflammatory drugs. V. [Tris(2-hydroxyethyl)methyl]ammonium 2-[2,6-dichlorophenyl)amino]phenyl-acetate. Acta Crystallogr. C53, 482-486.
7. Castellari, C., Sabatino, C., 1994. Anti-inflammatory drugs: 1-(2-hydroxyethyl) pyrrolidinium salt of diclofenac. Acta Crystallogr. C50, 1723-1726.
8. Castellari, C, Sabatino, C., 1996. Antiiflammatory drugs. III. Salts of diclofenac with N-(2-hydroxyethyl) piperidine, N-(2-hydroxyethyl) morpholine, N-(2-hydroxyethyl) piperazine. Acta Crystallogr. C52, 1708-1712.
9. Cools, A.A., Janssen, L.H.M., 1983. Influence of sodium ion-pair formation on transport kinetics of warfarin through octanol-impregnated membranes. J. Pharm. Pharmacol. 35, 689-691.
10. Danion, J.M., Schmidt, N., Welsch, M., Imbs, J.L., Singer, L., 1987. Interaction between non-steroidal anti-inflammatory agents and lithium salts. Encephale 13, 255-260.
11. Davies, N.M., Anderson, K.E., 1997. Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin. Pharmacokinet. 33, 184-213.
12. Falk, M., 1989. Transport of substances through lipid membranes. Part 9. Effect of the organic counter ions of the partition coefficient of non ionized acids. Pharmazie 44, 66-67.
13. Fini, A., Fazio, G., Orienti, I., Zecchi, V., Rapaport, I., 1991. Chemical properties-dissolution relationship. IV. Behaviour in solution of the diclofenac/N-(2-hydroxyethyl) pyrrolidine salt (DHEP). Pharm. Acta Helv. 7, 201-203.
14. Fini, A., Fazio, G, Rabasco, A.M., 1993. 1-Octanol/water partition of diclofenac salts. Acta Technol. Leg. Med. IV, 33-44.
15. Fini, A., Fazio, G., Rapaport, I., Rabasco, A.M., 1994a. Comportamento in soluzione di alcuni sali del diclofenac. Acta Technol. Leg. Med. V, 13-28.
16. Fini, A., Fazio, G., Rabasco, A.M., Fernandez-Hervas, M.J., 1994b. Self-association properties of diclofenac. Il Farmaco 49, 141-146.
17. Fini, A., Fazio, G., Feroci, G., 1995. Solubility and solubilization of non steroidal antiinflammatory drugs. Int. J. Pharm. 126, 95-102.
18. Fini, A., Feroci, G., Fazio, G., Fernandez-Hervas, M.J., Holgado, M.A., Rabasco, A.M., 1996. Effects of the counter-ions on the properties of diclofenac salts. Int. J. Pharm. Adv. 1, 269-284.
19. Hansch, C.H., Leo, A., 1979. Substituent Constants for Correlation Analysis in Chemistry and Biology. Wiley, New York.
20. Hurwitz, A.R., Carney, C.F., 1978. Enhancement of ampicilline partition behaviour. J. Pharm. Sci. 67, 138-140.
21. Inagi, T., Muramatsu, T., Nagai, H., Terada, H., 1981. Mechanism of indomethacin partition between n-octanol and water. Chem. Pharm. Bull. 29, 2330-2337.
22. James, K.C., 1986. Solubility and Related Properties. Marcel Dekker, New York, Ch. 3, pp. 91-126.
23. Kovala-Demertzi, D., Mentzafos, D., Terzis, A., 1993. Metal complexes of the anti-inflammatory drug sodium [2-[2,6-dichlorophenyl]amino]phenyl] acetate (diclofenac sodium). Molecular and crystal structure of cadmium diclofenac. Polyhedron 12, 1361-1370.
24. Kovala-Demertzi, D., Theodorou, A., Demertzis, A.M., Raptopoulou, C.P., Terzis, A., 1997. Synthesis and characterization of tetrakis-μ-2-[2,6 dichlorophenyl) amino] benzene acetodiaquodicopper(II) dihydrate and tetrakis-μ-2-[2,6 dichloro phenyl)amino] benezene aceto dimethylformammido dicopper(II). J. Inorg. Biochem. 65, 151-163.
25. Ledwige, M.T., Draper, S.M., Wilcock, D.J., Corrigan, O.I., 1996. Physicochemical characterization of diclofenac N-(2-hydroxyethyl) pyrrolidine: anhydrate and dihydrate crystalline forms. J. Pharm. Sci. 85, 16-21.
26. Lee, S.J., Kurihara-Bergstrom, T., Kim, S.W., 1987. Ion-paired drug diffusion through polymer membranes. Int. J. Pharm. 47, 59-73.
27. Maitani, Y., Kugu, M., Nakagaki, M., Nagai, T., 1993. Ionic size and behaviour of diclofenac salts in water and ethanol/water mixture by conductivity at 25°C. J. Pharm. Sci. 82, 1245-1249.
28. Maitani, Y., Kugo, M, Nagai, T., 1994. Permeation of diclofenac salts through silicone membrane. A mechanistic study of percutaneous absorption of ionizable drugs. Chem. Pharm. Bull. 42, 1297-1300.
29. Miller, L.G., Prichard, J.G., 1990. Current issues in NSAID therapy. Prim. Care 17, 589-601.
30. Nakhare, S., Jain, N.K., Verma, H.V., 1994. Iontophoretic cellophane membrane delivery of diclofenac sodium. Pharmazie 49, 672-675.
31. Nekroshus, A.S., Arzamastev, A.P., 1990. Complex stability of orthophen with transition metals. Farm. Zh. (Kiev) 1, 76-78
32. Chem. Abs. 116:24191w (1992).
33. Reimann, I.W., Frolich, J.C., 1981. Effects of diclofenac on lithium kinetics. Clin. Pharm. Ther. 30, 348-352.
34. Riess, W., Schmid, K., Botta, L., Kobayashi, K., Moppert, J., Schneider, W., Sioufi, A., Strusberg, A., Tomas, M., 1986. Die perkutane resorption of diclofenac. Arzneim. Forsch. 7, 1092-1096.
35. Roda, A., Minutello, A., Angellotti, M.A., Fini, A., 1990. Bile acid structure-activity relationship: evaluation of bile acid lipophilicity using 1-octanol/water partition coefficient and reverse phase HPLC. J. Lipid Res. 31, 1433-1443.
36. Rodriguez, L., Cini, M., Grecchi, R., 1989. Mathematical model of the partition of a non-dissociating drug: prednisone in two-phase W/O or O/W systems. Pharm. Acta Helv. 64, 5-6.
37. Rubino, J.Y., 1989. Solubilities and solid state properties of the sodium salts of drugs. J. Pharm. Sci. 78, 485-489.
38. Sallmann, A., 1986. The history of diclofenac. Am. J. Med. 80, 29-33.
39. Sastry, C.S., Prasad Tipirneni, A.S., Suryanarayana, M.V., 1989. Extractive spectrophotometric determination of some antiinflammatory agents with methylene violet. Analysts 114, 513-515.
40. Varghese, E., Khar, R.K., 1996. Enhanced skin permeation of diclofenac by iontophoresis: in vitro and in vivo studies. J. Control. Release 38, 21-27.
41. Yuko, Y., Hiroshi, T., 1988. Thermodynamic analysis of ion-pair partition of methyl orange anion with alkali metal cations in an octanol-water system. Chem. Pharm. Bull. 36, 2759-2765.